← brief for 2026-10-10 · Slowing decline

Estimating Long-Term Organ Damage Risk in Patients with Congenital Thrombotic Thrombocytopenic Purpura Receiving Recombinant ADAMTS13 Prophylaxis: A Structured Expert Elicitation Study

Article No results yet Peer reviewed

Key takeaways

This paper asks six doctors to guess the risk of organ damage in a rare blood disease. It is a survey of expert opinions, not a test on real patients. There are no new results from a clinical trial here.

Who did this work

Amie Padhiar · C. M. Burke · Mathilde Puls · Annie Berkley · Oliver Heard · Harneet Kaur (Takeda (Switzerland)) · Henri B. Wolff · Linda A Murphy

Source

Article · OpenAlex, CKD works · 2026-10-09
https://doi.org/10.1007/s12325-026-03786-y